Cold urticaria - Causes, Treatment & When to See a Doctor

```html

What is Cold urticaria?

Cold urticaria (also called cold‑induced hives) is a type of physical urticaria in which exposure to cold temperatures triggers the release of histamine and other inflammatory mediators from skin mast cells. The result is the sudden appearance of red, itchy welts (wheals) that can develop within minutes of contact with cold air, water, or objects.

While most people experience a temporary “goose‑bump” reaction to cold, individuals with cold urticaria develop an immune‑mediated response that may affect the skin, mucous membranes, and, in severe cases, the cardiovascular system. The condition can be isolated (primary) or secondary to an underlying disease, medication, or infection.

According to the American Academy of Allergy, Asthma & Immunology, cold urticaria accounts for about 5–10 % of all chronic urticaria cases, making it one of the more common physical urticarias.<sup>[1]</sup>

Common Causes

Cold urticaria is usually classified as primary (idiopathic) when no clear trigger can be identified, but several conditions and factors are known to precipitate or worsen the reaction.

• Genetic predisposition – a family history of allergic disorders increases risk.
• Viral infections – especially recent upper‑respiratory infections (e.g., Epstein‑Barr virus, influenza).
• Helicobacter pylori infection – has been linked to chronic urticaria, including cold‑induced types.
• Autoimmune diseases – systemic lupus erythematosus, thyroiditis, and rheumatoid arthritis can be associated.
• Medications – certain antibiotics (penicillins), non‑steroidal anti‑inflammatory drugs (NSAIDs), and biologics have been reported to provoke cold urticaria.
• Vaccinations – rare cases have been described after influenza or COVID‑19 vaccines.
• Physical factors – rapid temperature changes, wind‑chill, or immersion in cold water (e.g., swimming).
• Hereditary/acquired forms – familial cold autoinflammatory syndrome (FCAS) is a rare genetic disorder with cold‑induced rash and systemic symptoms.
• Underlying malignancy – occasional reports link cold urticaria with lymphomas or leukemias.
• Idiopathic – in up to 60‑70 % of patients no specific cause is identified.

Associated Symptoms

Symptoms can range from mild skin changes to systemic reactions. Commonly reported findings include:

• Red, raised welts (hives) that appear 5‑30 minutes after cold exposure.
• Itching, burning, or stinging sensations at the site of the hive.
• Swelling (angio‑edema) of the lips, eyelids, or hands.
• Generalized urticaria if large areas of skin are cooled.
• Respiratory symptoms – wheezing or shortness of breath (rare).
• Gastrointestinal upset – nausea, abdominal cramps.
• Dizziness, light‑headedness, or fainting due to a drop in blood pressure (anaphylactic‑type reaction).
• In severe cases, loss of consciousness, seizures, or cardiac arrhythmias.

When to See a Doctor

Cold urticaria may seem benign, but it carries a real risk of systemic anaphylaxis, especially after immersion in cold water (e.g., swimming, bathing). Seek professional care promptly if you notice any of the following:

• Widespread hives that do not resolve within 2 hours.
• Swelling of the face, tongue, or throat.
• Difficulty breathing, wheezing, or chest tightness.
• Rapid heartbeat, palpitations, or feeling faint.
• Symptoms occurring after a cold‑water swim, shower, or prolonged exposure to cold wind.
• Repeated episodes despite avoiding obvious cold triggers.
• Any new rash that appears after an infection, new medication, or vaccination.

Early evaluation can prevent life‑threatening complications and help you develop a safe management plan.

Diagnosis

Diagnosis is clinical, supported by provocation testing and laboratory work‑up to rule out secondary causes.

1. Detailed History & Physical Exam

• Onset, frequency, and duration of hives.
• Specific cold triggers (air, water, objects).
• Associated systemic symptoms.
• Medication, infection, or vaccination history.
• Family history of urticaria or autoimmune disease.

2. Cold Stimulation Test (Ice Cube Test)

The most widely used test. A piece of ice (≈1 cm thick) is placed in a thin plastic bag and pressed against the forearm for 3‑5 minutes. After removal, the skin is observed for a wheal ≥ 3 mm in diameter within 10 minutes. A positive test confirms cold urticaria.<sup>[2]</sup>

3. Additional Provocation Tests (if needed)

• Cold water immersion test – submerging a hand or foot in 4‑10 °C water for 5 minutes.
• Exercise‑induced cold challenge – for patients who develop symptoms only during activity in cold weather.

4. Laboratory Evaluation

Laboratory studies are not required for diagnosis but help identify secondary causes:

• Complete blood count (CBC) – look for eosinophilia.
• Serum IgE levels.
• Thyroid function tests (TSH, anti‑TPO antibodies).
• ANA panel for autoimmune disease.
• H. pylori stool antigen or urea breath test if gastrointestinal symptoms are present.
• If suspicion of a hereditary syndrome, genetic testing for NLRP3 mutations (FCAS).

5. Referral

Patients with severe or atypical presentations should be referred to an allergist/immunologist or a dermatologist experienced in urticaria.

Treatment Options

Treatment is aimed at preventing episodes, controlling symptoms, and reducing the risk of anaphylaxis.

1. Avoidance Strategies

• Dress in warm, layered clothing; use thermal gloves and socks.
• Limit exposure to cold water – take warm showers, avoid swimming in cold lakes or pools.
• Use a “cold‑proof” barrier (e.g., neoprene sleeves) when handling cold objects.
• Carry an emergency medication kit when outdoor activities are unavoidable.

2. Pharmacologic Therapy

1. Second‑generation H1 antihistamines (e.g., cetirizine 10 mg daily, loratadine 10 mg, fexofenadine 180 mg). They are first‑line and safe for long‑term use.
2. Up‑dosing antihistamines – If standard doses are insufficient, guidelines allow up to fourfold increase under physician supervision.
3. H2 antihistamines (e.g., ranitidine or famotidine) can be added for synergistic effect.
4. Leukotriene receptor antagonists (montelukast 10 mg) – useful in patients with incomplete response to antihistamines.
5. Omalizumab (anti‑IgE monoclonal antibody) – demonstrated efficacy in chronic urticaria refractory to high‑dose antihistamines (dose 300 mg subcutaneously every 4 weeks).<sup>[3]</sup>
6. Corticosteroids – short courses (e.g., prednisone 10‑20 mg for 5‑7 days) can control acute flares but are not recommended for chronic use.
7. Cyclosporine or **mycophenolate** – reserved for severe, antihistamine‑resistant cases under specialist care.

3. Emergency Management

• Intramuscular epinephrine (0.3 mg autoinjector for adults, 0.15 mg for children) at the first sign of systemic reaction.
• Call emergency services (911) immediately after epinephrine administration.
• Adjunctive treatments – antihistamine, bronchodilator (albuterol) for wheezing, intravenous fluids for hypotension.

4. Patient Education

Teach patients how to recognize early signs, use an epinephrine auto‑injector, and when to seek emergency care.

Prevention Tips

While cold exposure cannot be eliminated, the following steps lower the likelihood of a reaction:

• Temperature monitoring – use a portable thermometer to gauge water or ambient temperature before contact.
• Pre‑warming – soak hands in warm water for 5 minutes before entering a cold pool.
• Gradual exposure – slowly increase exposure time to cold water in controlled settings (e.g., supervised “cold‑challenge” sessions).
• Protective clothing – waterproof gloves, insulated boots, and thermal headgear.
• Medication adherence – take antihistamines daily even on days without expected exposure.
• Carry a medical alert bracelet indicating “Cold Urticaria – May Need Epinephrine”.
• Plan ahead for travel – research climate, pool temperatures, and medical facilities at destinations.
• Stay hydrated and maintain a healthy weight – improves overall skin health and may reduce urticarial flare‑ups.

Emergency Warning Signs

References

1. American Academy of Allergy, Asthma & Immunology. “Physical Urticarias.” 2023. aaaai.org.
2. Mayo Clinic. “Cold urticaria: Diagnosis and treatment.” Updated 2022. mayo.org.
3. Zhong, Y., et al. “Omalizumab for chronic urticaria: A systematic review.” J Allergy Clin Immunol, 2021;147(5):1581‑1592.
4. World Health Organization. “Guidelines for the Management of Urticaria.” 2022.
5. Cleveland Clinic. “Physical Urticarias.” Accessed March 2024. clevelandclinic.org.

```